Smith & Nephew: Acquisition Speculation, Cheap Valuations And Strong Fundamentals
Value Insight - at Seeking Alpha - Thu Dec 25, 8:58AM CST
SNN: 38.18 (+0.14), SYK: 96.00 (-0.61)
Osiris inks deal with Stryker to commercialize bone matrix
Seeking Alpha - at Seeking Alpha - Wed Dec 24, 12:19PM CST
OSIR: 14.87 (+0.13), SYK: 96.00 (-0.61)
Integra LifeSciences Hits 52-Week High on Portfolio Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 24, 12:00PM CST
Over the last few months, Integra LifeSciences Holdings Corporation (IART) has launched back-to-back products which we believe will enhance the overall product portfolio and also usher in more profitability for the company.
ZMH: 114.11 (+0.64), JNJ: 104.59 (+0.31), IART: 53.68 (+0.32), SYK: 96.00 (-0.61)
Stock Futures Edge Higher as U.S. Jobless Claims Decline
at The Street - Wed Dec 24, 7:50AM CST
Stock futures post minor gains in a holiday-shortened Christmas Eve session Wednesday after bouncing to record highs a day earlier.
SNN: 38.18 (+0.14), XOM: 93.78 (-0.81), SNE: 21.32 (+0.46), CVX: 113.47 (-0.48), SYK: 96.00 (-0.61)
Wall Street Breakfast: Global Stocks Rise Following Strong U.S. Growth
Wall Street Breakfast - Seeking Alpha - Wed Dec 24, 5:33AM CST
Economy U.S. benchmark indices closed at record highs yesterday, with the Dow soaring above 18,000 for the first time. The gains came as revised Commerce Department data reported U.S. GDP surging 5% in Q3, its strongest growth in more than a...
FDX: 176.42 (-0.52), WYN: 85.68 (+0.52), C: 54.54 (+0.12), WMT: 86.43 (-0.23), SNE: 21.32 (+0.46), DIS: 94.42 (-0.27), IPI: 13.86 (+0.07), UPS: 112.41 (-0.04), SNN: 38.18 (+0.14), SPY: 207.77 (+0.02), QQQ: 104.30 (+0.09), SMFG: 7.29 (+0.03), TGT: 74.65 (-0.04), DTV: 86.82 (-0.05), AAL: 51.43 (+1.22), MCD: 93.83 (-0.39), CORR: 6.34 (+0.05), SYK: 96.00 (-0.61)
European Stocks Trade Mixed as Investors Sit Still in Short Session
at The Street - Wed Dec 24, 5:26AM CST
With a short trading day on Christmas Eve, European investors are in unadventurous mood on Wednesday.
SNN: 38.18 (+0.14), BBVA: 9.79 (+0.01), SYK: 96.00 (-0.61)
Use of Composites in Orthopedic Industry to Reach $596 Million by 2020
PR Newswire Europe - Wed Dec 24, 3:57AM CST
NEW YORK and LONDON, December 24, 2014 /PRNewswire/ --
SNN: 38.18 (+0.14), JNJ: 104.59 (+0.31), MDT: 74.08 (+0.31), NUVA: 47.37 (+0.78), SYK: 96.00 (-0.61)
Watch for Stryker to Potentially Pullback After Gaining 1.71% Yesterday
Comtex SmarTrend(R) - Tue Dec 23, 4:02PM CST
Stryker (NYSE:SYK) traded in a range yesterday that spanned from a low of $94.07 to a high of $98.24. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $96.61 on volume of 3.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
SYK: 96.00 (-0.61)
SmarTrend Watching for Potential Pullback in Shares of Stryker After 1.71% Gain
Comtex SmarTrend(R) - Tue Dec 23, 4:02PM CST
Stryker (NYSE:SYK) traded in a range yesterday that spanned from a low of $94.07 to a high of $98.24. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $96.61 on volume of 3.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
SYK: 96.00 (-0.61)
Stryker & Osiris Team Up to Market Viable Bone Matrix - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 23, 2:50PM CST
Under the partnership, Stryker Corporation (SYK) will attain exclusive, worldwide rights to Osiris' viable bone matrix under the name BIO4.
ANIP: 55.24 (+1.79), OSIR: 14.87 (+0.13), AFFX: 9.80 (+0.05), SYK: 96.00 (-0.61)
Smith & Nephew (SNN) Stock Jumping Today on Takeover Speculation
at The Street - Tue Dec 23, 1:44PM CST
Smith & Nephew (SNN) stock is gaining today as reports suggest a takeover offer from Stryker (SYK) is forthcoming.
SNN: 38.18 (+0.14), SYK: 96.00 (-0.61)
Smith & Nephew up on takeout rumor
Seeking Alpha - at Seeking Alpha - Tue Dec 23, 1:23PM CST
SNN: 38.18 (+0.14), SYK: 96.00 (-0.61)
The Market Finally Values K2M Group Holdings
Dallas Salazar - at Seeking Alpha - Tue Dec 23, 9:04AM CST
MDT: 74.08 (+0.31), KTWO: 20.53 (-0.08), SYK: 96.00 (-0.61)
Osiris Announces a Strategic Partnership with Stryker for Marketing Osiris' Viable Bone Matrix
Business Wire - Mon Dec 22, 3:30PM CST
Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading cellular regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, announced today that it has entered into an exclusive, worldwide partnership with Stryker Corporation (NYSE:SYK) for the commercialization and development of Osiris' viable bone matrix tissue form. Stryker is a global leader in medical technology whose products and services are available in over 100 countries around the world. This partnership strategically aligns one of Osiris' leading regenerative medicine technologies with Stryker's innovative medical device portfolio; the resulting synergies will maximize the market potential.
OSIR: 14.87 (+0.13), SYK: 96.00 (-0.61)
Australia Resectoscopes Market Outlook to 2020: Key players covered include Olympus Corporation, Richard Wolf and KARL STORZ GmbH & Co
M2 - Thu Dec 18, 4:53AM CST
Research and Markets (http://www.researchandmarkets.com/research/8khfz7/australia) has announced the addition of the "Australia Resectoscopes Market Outlook to 2020" report to their offering. Our new report, "Australia Resectoscopes Market Outlook to 2020", provides key market data on the Australia Resectoscopes market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Rigid Resectoscopes and Resectoscopes Electrodes (Monopolar (Disposable and Reusable) Electrodes and Bipolar (Disposable and Reusable) Electrodes). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Resectoscopes market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Key Topics Covered: 1 List of Tables 2 Introduction 3 Resectoscopes Market, Australia 4 Overview of Key Companies in Australia, Resectoscopes Market 5 Appendix Companies Mentioned: - KARL STORZ GmbH & Co. KG - Olympus Corporation - Richard Wolf GmbH - Stryker Corporation For more information visit http://www.researchandmarkets.com/research/8khfz7/australia
SYK: 96.00 (-0.61)
Jim Cramer: These Charts Prove It's Oil-and-Gas vs. Everything Else
at The Street - Tue Dec 16, 10:01AM CST
Reams of stocks make sense on a pullback. And what looks bad? Anything even remotely connected to oil and gas.
CAH: 82.07 (+0.15), WMT: 86.43 (-0.23), PDCO: 48.79 (-0.02), JACK: 78.82 (-0.17), CFR: 70.74 (+0.17), RCL: 82.36 (+0.16), TGT: 74.65 (-0.04), LOW: 67.51 (-0.43), MSFT: 48.14 (-0.31), HSIC: 137.87 (+0.15), REGN: 400.12 (+6.07), YUM: 72.79 (+0.11), SYK: 96.00 (-0.61), MU: 34.91 (-0.06), BCR: 169.10 (-0.44), MCK: 209.79 (+0.58), STX: 68.82 (+0.17), EW: 130.75 (+1.17), WLP: 128.71 (+0.94), UAL: 64.93 (+2.45), CELG: 109.60 (+3.48), CBRL: 138.16 (+0.46), AZO: 617.43 (-3.87), STE: 66.76 (+0.85), MRK: 57.46 (+0.25), MCD: 93.83 (-0.39), SHW: 264.55 (+1.46), BIIB: 340.89 (+5.13), BDX: 139.90 (+1.44), BMRN: 88.18 (+0.89), CCL: 45.39 (+0.09), MDT: 74.08 (+0.31), SNA: 139.09 (unch), JBLU: 15.50 (+0.21), ADBE: 74.74 (+0.36), HUM: 144.38 (-0.31), RFMD: 16.59 (+0.29), EBAY: 57.10 (-0.12), DPZ: 95.39 (-0.23), SRCL: 133.27 (-0.16), XLF: 24.95 (-0.04), ZMH: 114.11 (+0.64), CY: 14.61 (+0.26), HD: 103.56 (-0.20), ORLY: 193.95 (-1.11), DIS: 94.42 (-0.27), LLY: 70.16 (+0.42), BMY: 59.15 (-0.01), WDC: 113.11 (-0.18), PLKI: 55.50 (+0.01), HPQ: 40.54 (+0.18), FRGI: 56.97 (+0.47), DIN: 101.87 (-0.40), DRI: 58.42 (-0.09), CI: 104.23 (-0.08), ABC: 91.60 (+0.18), TJX: 67.87 (-0.25), JWN: 78.14 (-0.58), AVGO: 100.72 (-0.06)
APAC Joint Replacement And Joint Reconstruction Market Through 2020 - Analysis of the $6.4 Billion Market
M2 - Tue Dec 16, 8:19AM CST
Research and Markets (http://www.researchandmarkets.com/research/whpkzp/apac_joint) has announced the addition of the "APAC Joint Replacement And Joint Reconstruction Market Through 2020" report to their offering. The Joint Replacement and Joint Reconstruction Market, comprising hip replacement, knee replacement, shoulder replacement and small joint replacement, in the Asia Pacific (APAC) is projected to reach $6.4 billion by 2020 with hip arthroplasty and knee arthroplasty are the most common types of joint replacements in APAC. Currently, the growth in the region is driven by chronic medical conditions such as osteoarthritis, rheumatoid arthritis and osteoporosis; technical advancement in implant designs; new joint biomaterials; and robotic and minimally invasive surgeries (MIS). Also, the market is pushed by favorable macroeconomic factors, especially in India and China. The future growth would be driven by the above-mentioned chronic conditions, younger patients undergoing joint replacement and requiring further revision surgeries during their lifetime. The market's growth would also be fuelled by improved healthcare infrastructure, better diagnosis facilities, and favorable macro economic factors such as increasing disposable income and rising healthcare expenditure. Also, a decline in sales and pricing pressure in the US and other developed markets has forced companies to increase their focus on the APAC region. China and India offer a huge potential for market growth due to their developing economies and the size of the population. The key attributes that will govern the market in this region will be innovation, technology, reduced cost and existing products that are refined. Key Topics Covered: - Market at a Glance - Summary - China Market for Joint Replacement and Joint Reconstruction (2007-2020) - Japan Market for Joint Replacement and Joint Reconstruction (2007-2020) - Australia Market for Joint Replacement and Joint Reconstruction (2007-2020) - India Market for Joint Replacement and Joint Reconstruction (2007-2020) - Korea Market for Joint Replacement and Joint Reconstruction (2007-2020) - Recent Industry Activity - Appendix - Research Methodology - Market segmentation - Joint Replacement and Joint Reconstruction - Definitions - Disclaimer Companies Mentioned - DePuy Medical Pty. Ltd - Implants International Ltd. - Japan Medical Dynamic Marketing Inc. (TSE:7600) - KYOCERA Medical Corporation - Mathys Medical - OMNI Life Science - Smith & Nephew plc (NYSE: SNN; LSE: SN) - Stryker Corporation(SYK) and Zimmer Holdings Inc (ZMH) - Waldemar LINK - Wright Medical Group Inc. (WMGI) For more information visit http://www.researchandmarkets.com/research/whpkzp/apac_joint
SNN: 38.18 (+0.14), WMGIZ: 4.60 (+0.02), SYK: 96.00 (-0.61)
United States Medical Equipment and Supplies Manufacturing Industry Analytic 2014-2021: Industry to reach $142.9 billion by 2021
M2 - Mon Dec 15, 8:12AM CST
Research and Markets (http://www.researchandmarkets.com/research/3ntjwz/medical_equipment) has announced the addition of Plunkett Research Ltd's new report "Medical Equipment and Supplies Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021" to their offering. Medical Equipment and Supplies Manufacturing Industry (U.S.) to reach $142.9 billion by 2021 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. This Report Features: 1. Historical data 2. Revenue forecasts, growth rates and CAGR 3. Operating ratios 4. Complete data for benchmarking a company to its industry and to specific leading companies 5. Benchmarking this industry to all U.S. industries 6. Deep profiles and financial histories/operating ratios for up to ten top U.S.-based companies Designed to benefit: - Analysis and Financial Modeling - Investment Professionals - Lenders - M&A Advisors - Appraisers - Consultants Key Data: Industry Summary - Revenues historical through 2013 - Revenues projected through 2021 - Employee Count 2007-2013 - Annual Growth Rate 2013 - CAGR 2006 through 2013 - CAGR 2014 through 2021 - Top U.S. Companies Employment and Establishments - Number of Firms 2007-2013 - Number of Establishments 2007-2013 - Employees, 2007-2013 - Average Annual Sales per Firm & per Establishment 2007-2013 - Sales per Employee Average Annual Operating Ratios - Revenue Compared to All Industries - Expenses Compared to All Industries - Profits & Income Taxes Compared to All Industries Benchmarks This Industry Compared to All Industries - Comparison of Revenues, Profits and Taxes to All Industries Industry Results, Publicly-Held Companies (U.S.), Average for all Companies - Industry Income Statement, Balance Sheet, Cash Flow Statement, 2008-2013 Top Companies Profiled & Ranked In-Depth Profiles, Financial Reports, Ranks & Executive Lists for Top U.S.-Based Corporations Top Companies Ranked - Market Capitalization - Employees - Revenue - Net Income - 3-Year Revenue Growth - 3-Year Income Growth - Return on Assets - Return on Equity - Return on Invested Capital List of Leading (Public and Private) Companies Comparison of Individual Top Publicly-Held Companies to Industry Averages, 2013 - Income Statements. Balance Sheets and Cash Flow Statements - 3M Company - Baxter International Inc - Becton Dickinson & Co - Boston Scientific Corp - DePuy Synthes Inc - Ethicon Inc - St Jude Medical Inc - St Jude Medical Neuromodulation - Stryker Corp - Zimmer Holdings Inc For more information visit http://www.researchandmarkets.com/research/3n..._equipment Source: Plunkett Research Ltd
ZMH: 114.11 (+0.64), BSX: 13.13 (+0.07), MMM: 166.96 (+0.09), BDX: 139.90 (+1.44), BAX: 74.45 (-0.04), SYK: 96.00 (-0.61)
INSIGHTEC Secures $59 Million in Equity Financing and Appoints Maurice R. Ferré, M.D., as Executive Chairman of the Board
PR Newswire - Mon Dec 15, 8:01AM CST
INSIGHTEC announced today that it closed on a $59 Million Series D financing led by major institutional investors in the United States and Asia.
SYK: 96.00 (-0.61)